About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Adipoq
adiponectin, C1Q and collagen domain containing
MGI:106675
91 phenotypes from 7 alleles in 13 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Adipoqtm1b(KOMP)Wtsi/Adipoqtm1b(KOMP)Wtsi
C57BL/6N-Adipoqtm1b(KOMP)Wtsi/Tcp
abnormal heart morphology J:211773
enlarged heart J:211773
Adipoqtm1b(KOMP)Wtsi/Adipoqtm1b(KOMP)Wtsi
C57BL/6NCrl-Adipoqtm1b(KOMP)Wtsi/Tcp
decreased pulmonary ventilation J:211773
Adipoqtm1Chan/Adipoq+
B6.129-Adipoqtm1Chan
abnormal leukocyte physiology J:122020
decreased circulating adiponectin level J:122020
increased leukocyte cell number J:122020
increased vascular endothelial cell adhesion J:122020
Adipoqtm1Chan/Adipoqtm1Chan
B6.129-Adipoqtm1Chan
abnormal leukocyte physiology J:122020
abnormal nitric oxide homeostasis J:122020
decreased circulating adiponectin level J:122020
decreased fatty acid beta-oxidation J:79122
normal homeostasis/metabolism phenotype J:79122
increased leukocyte cell number J:122020
increased vascular endothelial cell adhesion J:122020
Adipoqtm1Chan/Adipoqtm1Chan
involves: 129S1/Sv * 129X1/SvJ
abnormal lipid homeostasis J:138678
abnormal skeletal muscle fiber morphology J:138678
increased body weight J:138678
Adipoqtm1Chan/Adipoqtm1Chan
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
albuminuria J:136297
fused podocyte foot processes J:136297
oxidative stress J:136297
Adipoqtm1Far/Adipoqtm1Far
involves: 129S4/SvJae * C57BL/6J
impaired glucose tolerance J:111346
increased body weight J:111346
increased circulating glucose level J:111346
increased liver triglyceride level J:111346
increased percent body fat/body weight J:111346
increased susceptibility to diet-induced hepatic steatosis J:111346
increased total body fat amount J:111346
Adipoqtm1Far/Adipoqtm1Far
involves: C57BL/6J
impaired glucose tolerance J:111346
Adipoqtm1Ish/Adipoqtm1Ish
involves: 129S7/SvEvBrd * C57BL/6J
abnormal abdominal fat pad morphology J:199264
abnormal cardiovascular system morphology J:106599
abnormal cardiovascular system physiology J:106599
abnormal energy homeostasis J:199264
abnormal gas homeostasis J:199264
abnormal glucose homeostasis J:199264
abnormal hormone level J:199264
abnormal lipid level J:77479
abnormal osteoblast physiology J:199264
abnormal osteoclast morphology J:199264
abnormal skeleton morphology J:199264
abnormal skeleton physiology J:199264
abnormal urine homeostasis J:199264
abnormal vascular wound healing J:79350
abnormal vasodilation J:103106
abnormal white adipose tissue morphology J:199264
cardiac hypertrophy J:106599
congestive heart failure J:106599
decreased body weight J:199264
decreased bone mass J:199264
decreased bone mineral density J:199264
decreased bone ossification J:199264
decreased bone trabecula number J:199264
decreased food intake J:199264
decreased heart left ventricle muscle contractility J:106599
decreased heart rate J:199264
decreased insulin secretion J:199264
decreased osteoblast cell number J:199264
decreased systemic arterial blood pressure J:199264
decreased total fat pad weight J:199264
decreased trabecular bone volume J:199264
dilated heart left ventricle J:106599
hemorrhage J:106599
normal homeostasis/metabolism phenotype J:199264
hyperglycemia J:77479, J:103106
impaired glucose tolerance J:199264
increased adiponectin level J:199264
increased bone mass J:199264
increased bone mineral density J:199264
increased bone ossification J:199264
increased bone strength J:199264
increased carbon dioxide production J:199264
increased circulating adiponectin level J:199264
increased circulating free fatty acids level J:77479
increased circulating glucose level J:106599
increased circulating insulin level J:77479
increased circulating osteocalcin level J:199264
increased compact bone thickness J:199264
increased energy expenditure J:199264
increased noradrenaline level J:199264
increased osteoblast cell number J:199264
increased oxygen consumption J:199264
increased susceptibility to diet-induced obesity J:103106
increased susceptibility to induced morbidity/mortality J:106599
increased systemic arterial systolic blood pressure J:103106
increased trabecular bone volume J:199264
increased urine adrenaline level J:199264
insulin resistance J:77479
normal liver/biliary system phenotype J:199264
normal muscle phenotype J:199264
oxidative stress J:199264
pulmonary edema J:106599
pulmonary vascular congestion J:106599
normal skeleton phenotype J:199264
vascular restenosis J:79350
Adipoqtm1Pesch/Adipoqtm1Pesch
B6.129S7-Adipoqtm1Pesch
abnormal inguinal fat pad morphology J:210480
abnormal respiratory electron transport chain J:210480
decreased susceptibility to induced hypothermia J:210480
increased core body temperature J:210480
increased energy expenditure J:210480
increased oxygen consumption J:210480
Adipoqtm1Pesch/Adipoqtm1Pesch
involves: 129S7/SvEvBrd
abnormal gluconeogenesis J:107486
impaired glucose tolerance J:107486
Adipoqtm1Pesch/Adipoqtm1Pesch
involves: C57BL/6
maternal effect J:219264
Adipoqtm1Tka/Adipoq+
involves: 129S4/SvJae * C57BL/6
impaired glucose tolerance J:77876
insulin resistance J:77876
Adipoqtm1Tka/Adipoqtm1Tka
involves: 129S4/SvJae * C57BL/6
abnormal vascular wound healing J:77876
impaired glucose tolerance J:77876
increased circulating triglyceride level J:77876
insulin resistance J:77876
Tg(APOE-Adipoq)#Kry/0
involves: 129 * C57BL/6J
decreased bone mass J:199264
decreased bone ossification J:199264
decreased circulating osteocalcin level J:199264
decreased osteoblast cell number J:199264
increased circulating adiponectin level J:199264
increased trabecular bone volume J:199264

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory